The estrogen receptor beta agonist liquiritigenin enhances the inhibitory effects of the cholesterol biosynthesis inhibitor RO 48-8071 on hormone-dependent breast-cancer growth-Reference-Cited by-同舟云学术

The estrogen receptor beta agonist liquiritigenin enhances the inhibitory effects of the cholesterol biosynthesis inhibitor RO 48-8071 on hormone-dependent breast-cancer growth

Published:2022-01-17 Issue:1 Volume:192 Page:53-63
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Liang Yayun,Besch-Williford Cynthia,Hyder Salman M.^ORCID

Funder

U.S. Department of Defense

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-021-06487-y.pdf

Reference51 articles.

1. D’Abreo N, Hindenburg AA (2013) Sex hormone receptors in breast cancer. Vitam Horm 93:99–1331

2. Pasqualini JR, Katzenellenbogen BS (eds) (1996) Hormone dependent cancer. Marcel Dekker Inc, New York, p 579

3. Belachew EB, Sewasew DT (2021) Molecular mechanisms of endocrine resistance in estrogen-positive breast cancer. Front Endocrinol 12:599586

4. Fisher B, Redmond C, Fisher ER, Caplan R (1988) Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from national surgical adjuvant breast and bowel project protocol B-06. J Clin Oncol 6:1076–1087

5. Harrell JC, Dye WW, Allred DC et al (2006) Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes. Cancer Res 66:9308–9315

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Estrogen across Multiple Disease Mechanisms;Current Issues in Molecular Biology;2024-07-29

2. Polygonatum sibiricum component liquiritigenin restrains breast cancer cell invasion and migration by inhibiting HSP90 and chaperone-mediated autophagy;The Korean Journal of Physiology & Pharmacology;2024-07-01

3. The changes of intestinal microbiota and metabolomics during the inhibition of bladder cancer by liquiritigenin;Journal of Asian Natural Products Research;2024-06-13

4. Cyclopia extracts act as selective estrogen receptor subtype downregulators in estrogen receptor positive breast cancer cell lines: Comparison to standard of care breast cancer endocrine therapies and a selective estrogen receptor agonist and antagonist;Frontiers in Pharmacology;2023-03-13

5. Should oxidosqualene cyclase in the cholesterol biosynthetic pathway be considered an anti-cancer target?;Frontiers in Cell and Developmental Biology;2022-12-13